45 related articles for article (PubMed ID: 3358644)
1. Unpublished trials of alprazolam XR and their influence on its apparent efficacy for panic disorder.
Ahn-Horst RY; Turner EH
Psychol Med; 2024 Apr; 54(5):1026-1033. PubMed ID: 37853797
[TBL] [Abstract][Full Text] [Related]
2. Benzodiazepines versus placebo for panic disorder in adults.
Breilmann J; Girlanda F; Guaiana G; Barbui C; Cipriani A; Castellazzi M; Bighelli I; Davies SJ; Furukawa TA; Koesters M
Cochrane Database Syst Rev; 2019 Mar; 3(3):CD010677. PubMed ID: 30921478
[TBL] [Abstract][Full Text] [Related]
3. The Black Book of Psychotropic Dosing and Monitoring.
Schatzberg AF; Charles D
Psychopharmacol Bull; 2018 Jan; 48(1):64-153. PubMed ID: 29382960
[No Abstract] [Full Text] [Related]
4. Clinical pharmacology, clinical efficacy, and behavioral toxicity of alprazolam: a review of the literature.
Verster JC; Volkerts ER
CNS Drug Rev; 2004; 10(1):45-76. PubMed ID: 14978513
[TBL] [Abstract][Full Text] [Related]
5. Guidelines for the rational use of benzodiazepines. When and what to use.
Ashton H
Drugs; 1994 Jul; 48(1):25-40. PubMed ID: 7525193
[TBL] [Abstract][Full Text] [Related]
6. Treating panic.
Tyrer P
BMJ; 1989 Jan; 298(6668):201-2. PubMed ID: 2493860
[No Abstract] [Full Text] [Related]
7. Alprazolam use and dependence. A retrospective analysis of 30 cases of withdrawal.
Dickinson B; Rush PA; Radcliffe AB
West J Med; 1990 May; 152(5):604-8. PubMed ID: 2349800
[TBL] [Abstract][Full Text] [Related]
8. Effects of single doses of alprazolam and diazepam, alone and in combination with ethanol, on psychomotor and cognitive performance and on autonomic nervous system reactivity in healthy volunteers.
Linnoila M; Stapleton JM; Lister R; Moss H; Lane E; Granger A; Eckardt MJ
Eur J Clin Pharmacol; 1990; 39(1):21-8. PubMed ID: 2276384
[TBL] [Abstract][Full Text] [Related]
9. The effects of repeated doses of clomipramine and alprazolam on physiological, psychomotor and cognitive functions in normal subjects.
Allen D; Curran HV; Lader M
Eur J Clin Pharmacol; 1991; 40(4):355-62. PubMed ID: 2050170
[TBL] [Abstract][Full Text] [Related]
10. A review of evidence for GABergic predominance/glutamatergic deficit as a common etiological factor in both schizophrenia and affective psychoses: more support for a continuum hypothesis of "functional" psychosis.
Squires RF; Saederup E
Neurochem Res; 1991 Oct; 16(10):1099-111. PubMed ID: 1686635
[TBL] [Abstract][Full Text] [Related]
11. Sodium valproate and clonazepam for treatment-resistant panic disorder.
Ontiveros A; Fontaine R
J Psychiatry Neurosci; 1992 Jun; 17(2):78-80. PubMed ID: 1637803
[TBL] [Abstract][Full Text] [Related]
12. Benzodiazepines. Depressants or antidepressants?
Tiller JW; Schweitzer I
Drugs; 1992 Aug; 44(2):165-9. PubMed ID: 1382011
[No Abstract] [Full Text] [Related]
13. Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. II. Patient acceptance, side effects, and safety.
Noyes R; DuPont RL; Pecknold JC; Rifkin A; Rubin RT; Swinson RP; Ballenger JC; Burrows GD
Arch Gen Psychiatry; 1988 May; 45(5):423-8. PubMed ID: 3358644
[TBL] [Abstract][Full Text] [Related]
14. Psychopharmacological treatment of panic disorder and related states: a placebo controlled study of alprazolam.
Swinson RP; Pecknold JC; Kuch K
Prog Neuropsychopharmacol Biol Psychiatry; 1987; 11(2-3):105-13. PubMed ID: 3628823
[TBL] [Abstract][Full Text] [Related]
15. Secondary depression in panic disorder and agoraphobia. I. Frequency, severity, and response to treatment.
Lesser IM; Rubin RT; Pecknold JC; Rifkin A; Swinson RP; Lydiard RB; Burrows GD; Noyes R; DuPont RL
Arch Gen Psychiatry; 1988 May; 45(5):437-43. PubMed ID: 3282480
[TBL] [Abstract][Full Text] [Related]
16. Alprazolam, propranolol, and placebo in the treatment of panic disorder and agoraphobia with panic attacks.
Munjack DJ; Crocker B; Cabe D; Brown R; Usigli R; Zulueta A; McManus M; McDowell D; Palmer R; Leonard M
J Clin Psychopharmacol; 1989 Feb; 9(1):22-7. PubMed ID: 2651490
[TBL] [Abstract][Full Text] [Related]
17. Depression and panic anxiety: the effect of depressive co-morbidity on response to drug treatment of patients with panic disorder and agoraphobia.
Klerman GL
J Psychiatr Res; 1990; 24 Suppl 2():27-41. PubMed ID: 1980697
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
